http://www.fpnotebook.com/
Joint Injection
Aka: Joint Injection, Intra-articular Injection, Soft Tissue Injection- See Also
- Indications: Articular conditions
- Rheumatoid Arthritis
- Seronegative Spondyloarthropathy
- Crystal-induced arthritis
- Osteoarthritis
- Indications: Nonarticular conditions
- Fibrositis (Localized, systemic)
- Bursitis
- Subacromial bursitis
- Trochanteric Bursitis
- Anserine bursitis
- Prepatellar Bursitis
- Periarthritis
- Tenosynovitis or Tendonitis
- Dequervain's Tenosynovitis
- Trigger Finger
- Bicipital Tendonitis
- Tennis Elbow (Lateral Epicondylitis)
- Golfer's Elbow
- Plantar Fasciitis
- Neuritis
- Contraindications: Intra-articular Injection
- Overlying Cellulitis
- Severe coagulopathy
- Anticoagulant therapy (relative contraindication)
- Septic effusion
- More than 3 injections per year in weight bearing joint
- Lack of response after 2-4 injections
- Bacteremia
- Unstable joints
- Inaccessible joints
- Joint prosthesis
- Osteochondral Fracture
- Overlying soft tissue infection or dermatitis
- Precautions
- Do not inject directly into tendons
- Injection into tendon sheath is appropriate
- Tendon weakens with direct injection (rupture risk)
- Do not inject high risk tendons
- Avoid Achilles tendon injection
- Avoid Patella tendon injection
- Aspirate before injection to confirm no vessel
- Avoid needle trauma to cartilage on Joint Injection
- Limit Corticosteroid Injections to >4 week intervals
- Intra-articular Injections are typically limited to 3 month intervals
- Limit Corticosteroid to one large joint per visit
- Exercise caution with nearby nerves
- Withdraw needle if patient reports Paresthesias
- Example: Ulnar Nerve lies close to medial epicondyle
- Do not inject directly into tendons
- Complications
- Postinjection flare (2-5%)
- Relieved with ice to the area for 15 minutes/hour
- Resolves within 24 to 48 hours
- More common with longer acting Corticosteroids
- Steroid arthropathy (0.8%)
- Tendon rupture (<1%)
- Facial Flushing (<1%)
- Skin atrophy or depigmentation (<1%)
- Iatrogenic Infectious Arthritis (<.07%)
- Transient paresis of injected extremity (Rare)
- Hypersensitivity Reaction (rare)
- Asymptomatic pericapsular calcification (43%)
- Acceleration of cartilage attrition (unknown)
- Hyperglycemia in Diabetes Mellitus patients
- Single Intra-articular Injections do not typically affect blood sugars
- Soft tissue and peritendinous injections increase blood sugars for 5-21 days
- Wang (2006) J Hand Surg 31(6):979-81
- Younes (2007) Joint Bone Spine 74(5): 472-6
- Reference
- Postinjection flare (2-5%)
- Preparations: Based on duration and potency
- See Injectable Corticosteroid for dosing
- Short-Acting and Low Potency
- Intermediate-Acting and Intermediate Potency
- Prednisone
- Prednisolone tebutate (Hydeltra)
- Triamcinolone (Aristocort, Aristospan, Kenalog)
- Methylprednisolone acetate (Depo-Medrol)
- Long-Acting and High Potency
- Dexamethasone sodium phosphate (Decadron)
- Betamethasone (Celestone Soluspan)
- Preparations
- Preferred agents for large Joint Injections (longer duration but local skin reaction risk)
- Triamcinolone hexacetonide (Aristospan)
- Triamcinolone acetonide (Kenalog)
- Preferred agents for small joints and soft tissue
- Methylprednisolone acetate (Depo-medrol)
- Preferred agents for large Joint Injections (longer duration but local skin reaction risk)
- Needles
- Joint Injection
- Needle Gauges 22-27 with length of 1.5 inches (author prefers 27 gauge)
- Joint Aspiration
- Needle Gauges 18-20 with length of 1.5 inches
- Special Circumstances: Spinal needle
- Obesity interferes with joint or bursa access
- Trochanteric Bursitis
- Joint Injection
- References